IMUX Immunic, Inc.
Company Analysis
Latest News
🟢 Immunic is trading 9.33% up in pre-market
Immunic is trading at $7.76, up 9.33% in pre-market, with biotech-sector strength offering supportive context but no confirmed company-specific catalyst. - No...
🟢 Immunic is trading 5% up today amid broader biotech-sector strength
Immunic is trading at $7.00, up 5.11%, in a move that appears consistent with biotech-sector strength. - Biotech ETF XBI was up 2.20% in regular trading,...
🔴 Immunic is trading 5.3% down today as hotter inflation fuels rate-hike concerns
Immunic is trading at $6.53 (-5.30%) as hotter-than-forecast September inflation lifted Treasury yields and heightened rate-hike concerns. - Higher yields...
🔴 Immunic is trading 10.8% down with no clear company-specific catalyst
Immunic is trading 10.82% down at $7.09 on October 13, 2026, with no clear company-specific catalyst identified. - The biotech sector was weaker, with XBI...
🔴 Immunic is trading 6.8% down
Immunic is trading 6.79% lower at $7.41, alongside weakness in biotech stocks; no company-specific announcement explaining the move was identified as of...
🟢 Immunic is trading 11% up with no confirmed company-specific catalyst
Immunic is trading 10.71% up at $8.37 as of 11:59 a.m. ET on October 9, 2026, with no confirmed company-specific catalyst identified. - The latest company...
🟢 Immunic is trading 5.6% up; catalyst remains unclear
On October 9, 2026, Immunic is trading 5.6% higher at $7.98, with no confirmed catalyst identified for the intraday gain. - Its October 7 release announced...
🔴 Immunic is trading 5.7% down
Immunic is trading 5.7% lower at $8.15, with the reason for the October 2, 2026 decline unclear. - No clear company-specific announcement explaining the...
🔴 Immunic is trading 5% down
Immunic is trading 5.16% down at $8.82, with no clear company-specific catalyst identified for the October 1, 2026 decline in available search results. - The...
🟢 Immunic is trading 6% up in after-hours trading
Immunic is trading at $9.86, up 6.02% in after-hours trading; the reason for the move remains unclear. - The supplied market data is mixed and does not...
🔴 Immunic is trading 5% down with no clear company-specific catalyst
Immunic is trading at $9.02, down 5.15%, with no clear Immunic-specific catalyst identified for the September 29 decline. - The company’s latest listed...
🟢 Immunic is trading 5% up
Immunic is trading at $9.81, up 5.03%, with no clear company-specific catalyst identified for the September 28 move. - The latest surfaced company news was...
🔴 Immunic is trading 10% down today with no clear catalyst
Immunic is trading at $9.76 (-10.01%) after reversing lower during the September 23, 2026 session; the specific catalyst remains unclear. - No new...
🔴 Immunic is trading 6.1% down today; catalyst remains unclear
Immunic is trading 6.1% lower at $10.18 after reversing an early premarket gain; the specific catalyst remains unclear. - No new company-specific announcement...
🟢 Immunic is trading 7.2% up in pre-market amid broader biotech strength
Immunic is trading $11.62, up 7.2%, as biotechnology shares are broadly stronger pre-market; the move appears primarily sector-driven. - The price compares...
🔴 Immunic is trading 16.59% down in pre-market
Immunic is trading 16.59% lower at $9.04 in pre-market, with no clear company-specific catalyst identified for September 23, 2026. - The investor-relations...
🟢 Immunic is trading 6% up in pre-market as falling oil prices support equities
Immunic is trading 5.74% up now at $11.23, alongside a broadly stronger pre-market session. - The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average...
🔴 Immunic is trading 5.2% down today amid broader biotech weakness
Immunic is trading 5.2% down at $10.65 after extending a multi-session decline, primarily amid broader biotech weakness. - No fresh company-specific...
🟢 Immunic is trading 5.25% up in after-hours trading after Bank of America added 143,689 shares
Immunic is trading 5.25% up in after-hours trading at $11.82 after a filing showed Bank of America increased its position by 80,724.2%, purchasing an...
Bank of America Boosts Immunic Stake by 80,000% Amid Institutional Interest
Bank of America Corp DE increased its position in Immunic, Inc. (IMUX) by 80,724.2% during the first quarter. The institution purchased an additional 143,689...